DA-EPOCH-Rituximab/Metformin (RM) for Double Hit Lymphoma
Clinical trial NCT02815397 · TERMINATED
Trial details
- NCT number
- NCT02815397
- Sponsor
- Rush University Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-07-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.